((S)-2-[3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide)

ID: ALA3086782

Chembl Id: CHEMBL3086782

PubChem CID: 71661218

Max Phase: Preclinical

Molecular Formula: C21H31N5O

Molecular Weight: 369.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1

Standard InChI:  InChI=1S/C21H31N5O/c1-2-3-4-5-6-7-9-16-11-13-17(14-12-16)19-24-20(27-25-19)18-10-8-15-26(18)21(22)23/h11-14,18H,2-10,15H2,1H3,(H3,22,23)/t18-/m0/s1

Standard InChI Key:  JUZGDDYZTNXXNG-SFHVURJKSA-N

Alternative Forms

Associated Targets(Human)

SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SPHK2 Tchem Sphingosine kinase 2 (1579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.51Molecular Weight (Monoisotopic): 369.2529AlogP: 4.67#Rotatable Bonds: 9
Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.32CX LogP: 5.81CX LogD: 3.34
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -0.80

References

1. Baek DJ, MacRitchie N, Anthony NG, Mackay SP, Pyne S, Pyne NJ, Bittman R..  (2013)  Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors.,  56  (22): [PMID:24164513] [10.1021/jm401399c]
2. Adams DR, Tawati S, Berretta G, Rivas PL, Baiget J, Jiang Z, Alsfouk A, Mackay SP, Pyne NJ, Pyne S..  (2019)  Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2.,  62  (7): [PMID:30889352] [10.1021/acs.jmedchem.9b00162]
3. Ding T, Zhi Y, Xie W, Yao Q, Liu B..  (2021)  Rational design of SphK inhibitors using crystal structures aided by computer.,  213  [PMID:33454547] [10.1016/j.ejmech.2021.113164]

Source